clenbuterol and cardiovascular agents

clenbuterol has been researched along with cardiovascular agents in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banner, NR; Barton, PJ; Birks, EJ; Grindle, S; Hall, JL; Hardy, JP; Khaghani, A; Latif, N; Miller, LW; Rider, JE; Yacoub, MH1
Banner, NR; Birks, EJ; Bowles, CT; Burke, M; George, RS; Hardy, J; Khaghani, A; Tansley, PD; Yacoub, MH1
Amrani, M; Bahrami, T; Birks, EJ; Bougard, R; Bowles, CT; Dreyfus, G; George, RS; Hedger, M; Khaghani, A; Webb, C; Wilton, P; Yacoub, MH1

Trials

1 trial(s) available for clenbuterol and cardiovascular agents

ArticleYear
Left ventricular assist device and drug therapy for the reversal of heart failure.
    The New England journal of medicine, 2006, Nov-02, Volume: 355, Issue:18

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiovascular Agents; Clenbuterol; Combined Modality Therapy; Female; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Oxygen; Prospective Studies; Prosthesis Failure; Survival Rate

2006

Other Studies

2 other study(ies) available for clenbuterol and cardiovascular agents

ArticleYear
Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
    Circulation, 2005, Aug-30, Volume: 112, Issue:9 Suppl

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Cardiomyopathies; Cardiovascular Agents; Clenbuterol; Combined Modality Therapy; Convalescence; Cytoskeletal Proteins; Device Removal; Female; Gene Expression Profiling; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Integrins; Male; Middle Aged; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Postoperative Period; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome

2005
Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
    Circulation, 2011, Feb-01, Volume: 123, Issue:4

    Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Clenbuterol; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult

2011